Try our Advanced Search for more refined results

CORRECTED: FTC Pulls Antitrust Probe Over Yasmin Deals

By Django Gold (October 2, 2012, 12:00 AM EDT) -- Settlements between Bayer Schering Pharma AG and Barr Laboratories Inc. relating to patent infringement allegations over Bayer's Yasmin birth control drug will no longer be subject to antitrust scrutiny, as the Federal Trade Commission said on Monday that it is closing an investigation into the deals' potential competitive harms....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!